The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
A highly specific SpCas9 variant is identified by in vivo screening in yeast
Open accessAbstract
Despite the utility of CRISPR-Cas9 nucleases for genome editing, the potential for off-target activity limits their application, especially for therapeutic purposes. We developed a yeast-based assay to identify optimized Streptococcus pyogenes Cas9 (SpCas9) variants that enables simultaneous evaluation of on- and off-target activity. We screened a library of SpCas9 variants carrying random mutations in the REC3 domain and identified mutations that increased editing accuracy while maintaining editing efficiency. We combined four beneficial mutations to generate evoCas9, a variant that has fidelity exceeding both wild-type (79-fold improvement) and rationally designed Cas9 variants (fourfold average improvement), while maintaining near wild-type on-target editing efficiency (90% median residual activity). Evaluating evoCas9 on endogenous genomic loci, we demonstrated a substantially improved specificity and observed no off-target sites for four of the eight single guide RNAs (sgRNAs) tested. Finally, we showed that following long-term expression (40 d), evoCas9 strongly limited the nonspecific cleavage of a difficult-to-discriminate off-target site and fully abrogated the cleavage of two additional off-target sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, the absolute on-target activity of these Cas9 mutants are not dramatically reduced as compared to SpCas9 (Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Casini et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-nucleases have been successfully used to induce NHEJ to knockout genes or genomic regulatory elements25,26. This includes permanent repair of splicing defects in CFTR minigene models27 as an alternative to the transient and inefficient use of oligonucleotides or spliceosome-mediated RNA trans-splicing (SMaRT) strategies28,29.”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9-HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Casini et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“They found that the number of off-target sites reduced by 98.7%, 95.4% and 94.1%, respectively.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Casini et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“In addition, a series of optimized mutations in SpCas9 have greatly improved the editing specificity of Cas9 variants without substantially attenuating the editing activity.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Some active gRNAs for SpCas9-WT showed very low editing ability in SpCas9 variants.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method
Gietz, R. D., & Schiestl, R. H. (2007) · Nature Protocols · doi:10.1038/nprot.2007.13 · Cited by 2,785
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 492
Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
Aschenbrenner, S., Kallenberger, S. M., Hoffmann, M. D., Huck, A., Eils, R., & Niopek, D. (2020) · Science Advances · doi:10.1126/sciadv.aay0187 · Cited by 60
Delivery Approaches for Therapeutic Genome Editing and Challenges
Ates, I., Rathbone, T., Stuart, C., Bridges, P. H., & Cottle, R. N. (2020) · Genes · doi:10.3390/genes11101113 · Cited by 63
Cas9 deactivation with photocleavable guide RNAs
Zou, R. S., Liu, Y., Wu, B., & Ha, T. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.007 · Cited by 61
Caneva, A. D., Porro, F., Bortolussi, G., Sola, R., Lisjak, M., Barzel, A., Giacca, M., Kay, M. A., Vlahoviček, K., Zentilin, L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128863 · Cited by 61
High-fidelity SaCas9 identified by directional screening in human cells
Xie, H., Ge, X., Yang, F., Wang, B., Li, S., Duan, J., Lv, X., Cheng, C., Song, Z., Liu, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000747 · Cited by 59
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
Boutin, J., Cappellen, D., Rosier, J., Amintas, S., Dabernat, S., Bedel, A., & Moreau‐Gaudry, F. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0120 · Cited by 59
Klompe, S. E., & Sternberg, S. H. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0012 · Cited by 57
Molecular Dynamics Reveals a DNA-Induced Dynamic Switch Triggering Activation of CRISPR-Cas12a
Saha, A., Arantes, P. R., Hsu, R. V., Narkhede, Y. B., Jínek, M., & Palermo, G. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00929 · Cited by 59
CRISPR-Based Tools in Immunity
Simeonov, D. R., & Marson, A. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041522 · Cited by 57
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
Daga, S., Donati, F., Capitani, K., Croci, S., Tita, R., Giliberti, A., Valentino, F., Benetti, E., Fallerini, C., Niccheri, F., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0537-8 · Cited by 56
Rose, J. C., Popp, N. A., Richardson, C. D., Stephany, J. J., Mathieu, J., Wei, C. T., Corn, J. E., Maly, D. J., & Fowler, D. M. (2020) · Nature Communications · doi:10.1038/s41467-020-16542-9 · Cited by 61
Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing
Liu, R., Liang, L., Freed, E. F., & Gill, R. T. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.07.005 · Cited by 58
Ikeda, A., Fujii, W., Sugiura, K., & Naito, K. (2019) · Communications Biology · doi:10.1038/s42003-019-0627-8 · Cited by 57
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Choi, E., & Koo, T. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.002 · Cited by 57
Genome-wide detection of CRISPR editing in vivo using GUIDE-tag
Liang, S.-Q., Liu, P., Smith, J. L., Mintzer, E., Maitland, S., Dong, X., Yang, Q., Lee, J., Haynes, C. M., Zhu, L. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28135-9 · Cited by 54
Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing
Rabinowitz, R., & Offen, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.009 · Cited by 58
CRISPR/Cas system: An emerging technology in stem cell research
Valenti, M. T., Serena, M., Carbonare, L. D., & Zipeto, D. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.937 · Cited by 54
Rittiner, J. E., Moncalvo, M., Chiba‐Falek, O., & Kantor, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00148 · Cited by 53
Allemailem, K. S., Almatroodi, S. A., Almatroudi, A., Alrumaihi, F., Abdulmonem, W. A., Al‐Megrin, W. A. I., Aljamaan, A. N., Rahmani, A. H., & Khan, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087052 · Cited by 53
A CRISPR–Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis
Zhang, L., Zhang, H., Liu, Y., Zhou, J., Shen, W., Liu, L., Li, Q., & Chen, X. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27207 · Cited by 50
High-fidelity, hyper-accurate, and evolved mutants rewire atomic-level communication in CRISPR-Cas9
Skeens, E., Sinha, S., Ahsan, M., D’Ordine, A. M., Jogl, G., Palermo, G., & Lisi, G. P. (2024) · Science Advances · doi:10.1126/sciadv.adl1045 · Cited by 53
Catalytic-state structure and engineering of Streptococcus thermophilus Cas9
Zhang, Y., Zhang, H., Xu, X., Wang, Y., Chen, W., Wang, Y., Wu, Z., Tang, N., Wang, Y., Zhao, S., et al. (2020) · Nature Catalysis · doi:10.1038/s41929-020-00506-9 · Cited by 49
Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage
Zuo, Z., & Liu, J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.013 · Cited by 51
Concerns regarding ‘off-target’activity of genome editing endonucleases
Kadam, U. S., Shelake, R. M., Chavhan, R. L., & Suprasanna, P. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.03.027 · Cited by 47
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Ferrari, S., Vavassori, V., Canarutto, D., Jacob, A., Castiello, M. C., Omer, A., & Genovese, P. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618378 · Cited by 52
Current status of the application of gene editing in pigs
Tanihara, F., Hirata, M., & Otoi, T. (2021) · Journal of Reproduction and Development · doi:10.1262/jrd.2021-025 · Cited by 49
Palacios, A. M., Korus, P., Wilkens, B. G. C., Heshmatpour, N., & Patnaik, S. R. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1342193 · Cited by 49
Multiplex nucleotide editing by high-fidelity Cas9 variants with improved efficiency in rice
Xu, W., Song, W., Yang, Y., Wu, Y. C., Lv, X., Yuan, S., Liu, Y., & Yang, J. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-2131-1 · Cited by 47
Hulton, C. H., Costa, E. A., Shah, N., Quintanal-Villalonga, À., Heller, G., de Stanchina, E., Rudin, C. M., & Poirier, J. T. (2020) · Nature Cancer · doi:10.1038/s43018-020-0040-8 · Cited by 48
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 46
CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
Chemello, F., Olson, E. N., & Bassel‐Duby, R. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.053 · Cited by 47
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 48
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
Huang, H., Huang, G., Tan, Z., Hu, Y., Shan, L., Zhou, J., Zhang, X., Ma, S., Lv, W., Huang, T., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01296-1 · Cited by 46
Kulcsár, P. I., Tálas, A., Tóth, E., Nyeste, A., Ligeti, Z., Welker, Z., & Welker, E. (2020) · Nature Communications · doi:10.1038/s41467-020-15021-5 · Cited by 45
Improvements of TKC Technology Accelerate Isolation of Transgene-Free CRISPR/Cas9-Edited Rice Plants
He, Y., Min, Z., Lihao, W., Wu, J., Wang, Q., Wang, R., & Zhao, Y. (2019) · Rice Science · doi:10.1016/j.rsci.2018.11.001 · Cited by 46
Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety
Teboul, L., Hérault, Y., Wells, S. E., Qasim, W., & Pavlovic, G. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.03.015 · Cited by 47
PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Acharya, S., Ansari, A. H., Das, P. K., Hirano, S., Aich, M., Rauthan, R., Mahato, S., Maddileti, S., Sarkar, S., Kumar, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49233-w · Cited by 47
Nadakuduti, S. S., Starker, C. G., Ko, D. K., Jayakody, T. B., Buell, C. R., Voytas, D. F., & Douches, D. S. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00110 · Cited by 44
Okafor, I. C., Singh, D., Wang, Y., Jung, M., Wang, H., Mallon, J. P., Bailey, S., Lee, J. K., & Ha, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1058 · Cited by 45
Kulcsár, P. I., Tálas, A., Ligeti, Z., Krausz, S. L., & Welker, E. (2022) · Nature Communications · doi:10.1038/s41467-022-34527-8 · Cited by 46
Thean, D., Chu, H. Y., Fong, J. H. C., Chan, B. K. C., Zhou, P., Kwok, C. C. S., Chan, Y. M., Mak, S. Y. L., Choi, G. C. G., Ho, J. W. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29874-5 · Cited by 44
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 43
Bodai, Z., Bishop, A. L., Gantz, V. M., & Komor, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-29989-9 · Cited by 44
Battling CRISPR-Cas9 off-target genome editing
Li, D., Zhou, H., & Zeng, X. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09485-5 · Cited by 45
Paving the way towards precise and safe CRISPR genome editing
Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 43
Wide Horizons of CRISPR-Cas-Derived Technologies for Basic Biology, Agriculture, and Medicine
Molla, K. A., Karmakar, S., & Islam, T. (2020) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-0616-2_1 · Cited by 42
Zhou, J., Luan, X., Liu, Y., Wang, L., Wang, J., Yang, S., Liu, S., Zhang, J., Liu, H., & Yao, D. (2023) · Plants · doi:10.3390/plants12071478 · Cited by 43
Feng, Y.-L., Liu, S., Chen, R.-D., & Xie, A. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000282 · Cited by 42
Bhattacharyya, N., Anand, U., Kumar, R. S., Ghorai, M., Aftab, T., Jha, N. K., Rajapaksha, A. U., Bundschuh, J., Bontempi, E., & Dey, A. (2022) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01474-1 · Cited by 42
Precise and broad scope genome editing based on high-specificity Cas9 nickases
Wang, Q., Liu, J., Janssen, J. M., Le Bouteiller, M., Frock, R. L., & Gonçalves, M. A. F. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1236 · Cited by 41
Negative DNA supercoiling induces genome-wide Cas9 off-target activity
Newton, M. D., Losito, M., Smith, Q. M., Parnandi, N., Taylor, B. J., Akçakaya, P., Maresca, M., van Eijk, P., Reed, S. H., Boulton, S. J., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.008 · Cited by 41
Goel, K., & Ploski, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.914430 · Cited by 41
Oura, S., Noda, T., Morimura, N., Hitoshi, S., Nishimasu, H., Nagai, Y., Nureki, O., & Ikawa, M. (2021) · Communications Biology · doi:10.1038/s42003-021-02304-w · Cited by 40
Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
Feng, S., Wang, Z., Li, A., Xie, X., Liu, J., Li, S., Li, Y., Wang, B., Hu, L., Yang, L., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.803252 · Cited by 40
SgRNA engineering for improved genome editing and expanded functional assays
Dong, C., Gou, Y., & Lian, J. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102697 · Cited by 37
Impact of Genetic Variation on CRISPR-Cas Targeting
Canver, M. C., Joung, J. K., & Pinello, L. (2018) · The CRISPR Journal · doi:10.1089/crispr.2017.0016 · Cited by 36
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
Bischof, J., Hierl, M., & Koller, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042243 · Cited by 36
Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing
Karp, H., Zoltek, M., Wasko, K. M., Vazquez, A. L., Brim, J. I., Ngo, W., Schepartz, A., & Doudna, J. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf105 · Cited by 37
DNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells
Chen, X., & Gonçalves, M. A. F. V. (2018) · iScience · doi:10.1016/j.isci.2018.08.001 · Cited by 36
Growth-coupled high throughput selection for directed enzyme evolution
Li, Z., Deng, Y., & Yang, G. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108238 · Cited by 34
Engineering Cas9 for human genome editing
Slaymaker, I. M., & Gaudelli, N. M. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.03.004 · Cited by 34
The application of genome editing technology in fish
Lü, J., Fang, W., Huang, J., & Li, S. (2021) · Marine Life Science & Technology · doi:10.1007/s42995-021-00091-1 · Cited by 36
Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a
Swartjes, T., Staals, R. H. J., & John van der, O. O. S. T. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190563 · Cited by 37
Rational Engineering of CRISPR-Cas9 Nuclease to Attenuate Position-Dependent Off-Target Effects
Zuo, Z., Babu, K., Ganguly, C., Zolekar, A., Newsom, S. N., Rajan, R., Wang, Y.-C., & Liu, J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0076 · Cited by 32
CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications
Burbano, D. A., Kiattisewee, C., Karanjia, A. V., Cardiff, R. A. L., Faulkner, I., Sugianto, W., & Carothers, J. M. (2024) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100522-114706 · Cited by 34
CRISPR/Cas-Mediated Genome Engineering in Plants: Application and Prospectives
Mishra, S., Nayak, S., Tuteja, N., Poosapati, S., Swain, D. M., & Sahoo, R. K. (2024) · Plants · doi:10.3390/plants13141884 · Cited by 35
Harnessing the evolving CRISPR/Cas9 for precision oncology
Li, T., Li, S., Kang, Y., Zhou, J., & Yi, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05570-4 · Cited by 35
Artificial intelligence used in genome analysis studies
D’Agaro, E. (2018) · The EuroBiotech Journal · doi:10.2478/ebtj-2018-0012 · Cited by 33
Genome-Wide Off-Target Analysis in CRISPR-Cas9 Modified Mice and Their Offspring
Yan, D., Li, H., Zhao, L., Koopman, P. A., Zhang, F., & Huang, J. X. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400503 · Cited by 35
CRISPR Interference–Potential Application in Retinal Disease
Peddle, C. F., Fry, L. E., McClements, M. E., & MacLaren, R. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072329 · Cited by 33
Strategies for Enhancing the Homology-Directed Repair Efficiency of CRISPR-Cas Systems
Sun, W., Liu, H., Yin, W., Qiao, J., Zhao, X., & Liu, Y. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0039 · Cited by 33
Chen, G., Wei, T., Yang, H., Li, G., & Li, H. (2022) · Cells · doi:10.3390/cells11192964 · Cited by 33
Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies
Nguyen, Q., Lim, K. R. Q., & Yokota, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030733 · Cited by 33
Directed Evolution of Plant Processes: Towards a Green (r)Evolution?
Gionfriddo, M., Gara, L. D., & Loreto, F. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.08.004 · Cited by 31
Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
Lainšček, D., Forstnerič, V., Mikolič, V., Malenšek, Š., Pečan, P., Benčina, M., Sever, M., Podgornik, H., & Jerala, R. (2022) · Nature Communications · doi:10.1038/s41467-022-31386-1 · Cited by 34
van de Vrugt, H. J., Harmsen, T., Riepsaame, J., Alexantya, G., van Mil, S. E., de Vries, Y., Ali, R. B., Huijbers, I. J., Dorsman, J. C., Wolthuis, R. M. F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36506-w · Cited by 33
Synthetic chimeric nucleases function for efficient genome editing
Liu, R., Liang, L., Freed, E. F., Chang, H., Oh, E. J., Liu, Z., Garst, A. D., Eckert, C. A., & Gill, R. T. (2019) · Nature Communications · doi:10.1038/s41467-019-13500-y · Cited by 33
Enrichment strategies to enhance genome editing
Mikkelsen, N. S., & Bak, R. O. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00943-1 · Cited by 32
Modulating CRISPR/Cas9 genome-editing activity by small molecules
Chen, S., Chen, D., Liu, B., & Haisma, H. J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.018 · Cited by 32
CRISPR/Cas9—A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects
Ahmad, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911482 · Cited by 30
Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease
Chen, W., Zhang, H., Zhang, Y., Wang, Y., Gan, J., & Ji, Q. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000496 · Cited by 31
Linking CRISPR–Cas9 double-strand break profiles to gene editing precision with BreakTag
Longo, G. M. C., Sayols, S., Kotini, A. G., Heinen, S., Möckel, M. M., Beli, P., & Roukos, V. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02238-8 · Cited by 32
ABE-ultramax for high-efficiency biallelic adenine base editing in zebrafish
Qin, W., Liang, F., Lin, S., Petree, C., Huang, K., Zhang, Y., Li, L., Varshney, P., Mourrain, P., Liu, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49943-1 · Cited by 30
Engineering a New Generation of Gene Editors: Integrating Synthetic Biology and AI Innovations
Chia, B. S., Seah, S., Wang, B., Shen, K., Srivastava, D., & Chew, W. L. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00686 · Cited by 31
Peeling back the layers of immunogenicity in Cas9-based genomic medicine
Stigzelius, V., Cavallo, A. L., Chandode, R. K., & Nitsch, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.045 · Cited by 30
Genome editing approaches to β-hemoglobinopathies
Brusson, M., & Miccio, A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.025 · Cited by 29
Gene editing prospects for treating inherited retinal diseases
Benati, D., Patrizi, C., & Recchia, A. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106473 · Cited by 28
Matsumoto, D., Matsugi, E., Kishi, K., Inoue, Y., Nigorikawa, K., & Nomura, W. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102124 · Cited by 28
CRISPR/Cas based gene editing: marking a new era in medical science
Prasad, K. M., George, A., Ravi, N. S., & Mohankumar, K. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06479-7 · Cited by 27
Maghsoud, Y., Jayasinghe‐Arachchige, V. M., Kumari, P., Cisneros, G. A., & Liu, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01284 · Cited by 27
Kelkar, A., Zhu, Y., Groth, T., Stolfa, G., Stablewski, A. B., Singhi, N., Nemeth, M. J., & Neelamegham, S. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.006 · Cited by 27
Li, J., Wu, P., Cao, Z., Huang, G., Lu, Z., Yan, J., Zhang, H., Zhou, Y., Liu, R., Chen, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113765 · Cited by 26
Directed evolution expands CRISPR–Cas12a genome-editing capacity
Ma, E., Chen, K., Shi, H., Wasko, K. M., Esain-Garcia, I., Trinidad, M. I., Zhou, K., Ye, J., & Doudna, J. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf649 · Cited by 27
Basic Principles and Clinical Applications of CRISPR-Based Genome Editing
Lim, J. M., & Kim, S. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.2.105 · Cited by 26
Naeem, M., Alkhodairy, H. F., Ashraf, I., & Khalil, A. B. (2022) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-022-07266-7 · Cited by 27
Advances in understanding disease mechanisms and potential treatments for Crigler–Najjar syndrome
Bortolussi, G., & Muro, A. F. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1495558 · Cited by 27
Engineering Cas9: next generation of genomic editors
Kovalev, M. A., Davletshin, A. I., & Karpov, D. S. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13056-y · Cited by 29
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system
Wang, L., & Han, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38588 · Cited by 26
Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools
Zhu, Y., & Huang, Z. (2018) · National Science Review · doi:10.1093/nsr/nwy150 · Cited by 26
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease
Baker, C. M., & Hayden, M. S. (2020) · F1000Research · doi:10.12688/f1000research.23185.1 · Cited by 26
Metadata
- Authors
- Casini, A., Olivieri, M., Petris, G., Montagna, C., Reginato, G., Maule, G., Lorenzin, F., Prandi, D., Romanel, A., Demichelis, F., Inga, A., & Cereseto, A.
- Affiliations
- University of Trento (IT)
- Corresponding author
- Casini, Antonio
- Cereseto, Anna
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2018-01-29
- Volume
- 36
- Issue
- 3
- Pages
- 265-271
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC6066108
- OpenAlex
- W2787206763
- Cited by
- 493
- References
- 44
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 65 · 2023: 43 · 2022: 82 · 2021: 62 · 2020: 70 · 2019: 63 · 2018: 26
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, other-oa)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Funders
- Università degli Studi di Trento
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- SpCas9, off-target effects, editing specificity, yeast-based screening, single guide RNA, genome editing, CRISPR/Cas9
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Mutation, Streptococcus pyogenes, Substrate Specificity, RNA, Guide, Kinetoplastida, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
